Sartorius and UK-based startup SPARTA Biodiscovery have partnered on SPARTA’s analysis platform, designed to help accelerate the development, manufacture, and quality control of nanoparticles for biopharmaceuticals. Nanoparticles are small polymer or lipid capsules that act as carriers to deliver active agents to the target cells. As part of the alliance, Sartorius will invest up to £3.5 million in a minority shareholding in SPARTA through its corporate investment unit Sartorius Ventures.   Th...